Cargando…

Improved Long-Term Survival of Patients with Recurrent Medulloblastoma Treated with a “MEMMAT-like” Metronomic Antiangiogenic Approach

SIMPLE SUMMARY: About 30% of patients with medulloblastoma experience recurrence, which is usually incurable despite intensive chemotherapy. The aim of our retrospective study was to evaluate a novel combinatorial metronomic antiangiogenic approach (“MEMMAT-like”) for recurrent medulloblastoma consi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Slavc, Irene, Mayr, Lisa, Stepien, Natalia, Gojo, Johannes, Aliotti Lippolis, Maria, Azizi, Amedeo A., Chocholous, Monika, Baumgartner, Alicia, Hedrich, Cora S., Holm, Stefan, Sehested, Astrid, Leblond, Pierre, Dieckmann, Karin, Haberler, Christine, Czech, Thomas, Kool, Marcel, Peyrl, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9601092/ https://www.ncbi.nlm.nih.gov/pubmed/36291912 http://dx.doi.org/10.3390/cancers14205128

Ejemplares similares

MBCL-43. RECURRENT MEDULLOBLASTOMA – LONG-TERM SURVIVAL WITH A “MEMMAT” BASED ANTIANGIOGENIC APPROACH
por: Slavc, Irene, et al.
Publicado: (2020)

Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen: A Nonrandomized Controlled Trial
por: Peyrl, Andreas, et al.
Publicado: (2023)

DDEL-05. Intraventricular therapy with topotecan is feasible and safe: Experience in 50 pediatric patients with various malignant brain tumors
por: Peyrl, Andreas, et al.
Publicado: (2022)

Proof-of-Concept for Liquid Biopsy Disease Monitoring of MYC-Amplified Group 3 Medulloblastoma by Droplet Digital PCR
por: Stepien, Natalia, et al.
Publicado: (2023)

Retrospective National “Real Life” Experience of the SFCE with the Metronomic MEMMAT and MEMMAT-like Protocol
por: Winnicki, Camille, et al.
Publicado: (2023)

ETMR-10. EARLY FOCAL RADIOTHERAPY AND TEMOZOLOMIDE FOLLOWING COMPLETE RESECTION APPEAR SUPERIOR TO INTENSIVE CHEMOTHERAPY AND DELAYED RADIOTHERAPY IN CHILDREN WITH EMBRYONAL TUMORS WITH MULTILAYERED ROSETTES (ETMR)
por: Mayr, Lisa, et al.
Publicado: (2020)

Potential Importance of Early Focal Radiotherapy Following Gross Total Resection for Long-Term Survival in Children With Embryonal Tumors With Multilayered Rosettes
por: Mayr, Lisa, et al.
Publicado: (2020)

DDEL-03. LONG-TERM INTRAVENTRICULAR THERAPY ALTERNATING ETOPOSIDE AND LIPOSOMAL CYTARABINE: EXPERIENCE IN 75 CHILDREN AND ADOLESCENTS WITH MALIGNANT BRAIN TUMORS
por: Stepien, Natalia, et al.
Publicado: (2020)

High impact of miRNA-4521 on FOXM1 expression in medulloblastoma
por: Senfter, Daniel, et al.
Publicado: (2019)

The Site of Origin of Medulloblastoma: Surgical Observations Correlated to Molecular Groups
por: Ciobanu-Caraus, Olga, et al.
Publicado: (2023)

EPEN-49. RESPONSE OF RECURRENT EPENDYMOMA TO MEMMAT BASED METRONOMIC ANTIANGIOGENIC COMBINATION THERAPY UTILIZING TAPERED BEVACIZUMAB AND MAINTENANCE THERAPY WITH CELECOXIB AND FENOFIBRATE
por: Gillan, Eileen
Publicado: (2020)

TRLS-08. EXPERIENCE WITH THE SELECTIVE FIBROBLAST GROWTH FACTOR INHIBITOR ERDAFITINIB IN THREE PEDIATRIC PATIENTS WITH CNS TUMORS
por: Stepien, Natalia, et al.
Publicado: (2023)

Placement of EVD in pediatric posterior fossa tumors: safe and efficient or old-fashioned? The Vienna experience
por: Hedrich, Cora, et al.
Publicado: (2023)

RARE-20. A RARE CASE OF A PRIMARY CENTRAL NERVOUS SYSTEM NEUROENDOCRINE CARCINOMA AND SUCCESSFULL THERAPY IN A FIVE-YEAR-OLD CHILD
por: Stepien, Natalia, et al.
Publicado: (2021)

SURG-02. The site of origin of medulloblastoma: Does the neurosurgical perspective support the current concept from molecular data?
por: Ciobanu-Caraus, Olga, et al.
Publicado: (2022)

Atypical teratoid rhabdoid tumor: improved long-term survival with an intensive multimodal therapy and delayed radiotherapy. The Medical University of Vienna Experience 1992–2012
por: Slavc, Irene, et al.
Publicado: (2014)

Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma
por: Araki, Asuka, et al.
Publicado: (2016)

Prospective Evaluation of Kidney Function in Long-Term Survivors of Pediatric CNS Tumors
por: Stepien, Natalia, et al.
Publicado: (2022)

Does the interval from tumour surgery to radiotherapy influence survival in paediatric high grade glioma?
por: Azizi, Amedeo A., et al.
Publicado: (2018)

Unique Finding of a Primary Central Nervous System Neuroendocrine Carcinoma in a 5-Year-Old Child: A Case Report
por: Stepien, Natalia, et al.
Publicado: (2022)

Infiltrative gliomas of the thalamus in children: the role of surgery in the era of H3 K27M mutant midline gliomas
por: Dorfer, Christian, et al.
Publicado: (2020)

MBCL-33. RARE PULMONARY TOXICITY IN THREE MEDULLOBLASTOMA PATIENTS UNDERGOING ANTIANGIOGENIC METRONOMIC COMBINATION THERAPY
por: Lenzen, Alicia, et al.
Publicado: (2020)

Novel Insights into Diagnosis, Biology, and Treatment of Primary Diffuse Leptomeningeal Melanomatosis
por: Baumgartner, Alicia, et al.
Publicado: (2021)

HGG-44. DEFECTS OF MISMATCH REPAIR PROTEINS IN PEDIATRIC HIGH GRADE GLIOMAS
por: Haberler, Christine, et al.
Publicado: (2020)

Clinical applicability of miR517a detection in liquid biopsies of ETMR patients
por: Madlener, Sibylle, et al.
Publicado: (2023)

ATRT-07. CLINICAL APPLICABILITY OF C19MC MIRNA DETECTION IN LIQUID BIOPSIES OF ETMR PATIENTS
por: Madlener, Sibylle, et al.
Publicado: (2023)

Pharmacokinetics of metronomic temozolomide in cerebrospinal fluid of children with malignant central nervous system tumors
por: Büsker, Sören, et al.
Publicado: (2022)

Pharmacokinetics of Bevacizumab in Three Patients Under the Age of 3 Years with CNS Malignancies
por: Gojo, Johannes, et al.
Publicado: (2017)

Cerebrospinal fluid penetration of targeted therapeutics in pediatric brain tumor patients
por: Guntner, Armin Sebastian, et al.
Publicado: (2020)

HGG-50. Specific sensitivity of pediatric high-grade glioma with ATRX inactivation to PARP inhibitor combinations
por: Laemmerer, Anna, et al.
Publicado: (2022)

Management of choroid plexus tumors—an institutional experience
por: Hosmann, Arthur, et al.
Publicado: (2019)

Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib
por: Bocci, G, et al.
Publicado: (2008)

Acrolein: unwanted side product or contribution to antiangiogenic properties of metronomic cyclophosphamide therapy?
por: Günther, M, et al.
Publicado: (2008)

Personalized Treatment of H3K27M-Mutant Pediatric Diffuse Gliomas Provides Improved Therapeutic Opportunities
por: Gojo, Johannes, et al.
Publicado: (2020)

Cerebrospinal Fluid Penetration and Combination Therapy of Entrectinib for Disseminated ROS1/NTRK-Fusion Positive Pediatric High-Grade Glioma
por: Mayr, Lisa, et al.
Publicado: (2020)

Effectiveness of metronomic chemotherapy in a child with medulloblastoma: A case report
por: Lygina, Elena, et al.
Publicado: (2023)

TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAF(V600E)/TERT promoter double-mutated glioma
por: Gabler, Lisa, et al.
Publicado: (2019)

Determination of a Tumor-Promoting Microenvironment in Recurrent Medulloblastoma: A Multi-Omics Study of Cerebrospinal Fluid
por: Reichl, Bernd, et al.
Publicado: (2020)

Resolving medulloblastoma cellular architecture by single-cell genomics
por: Hovestadt, Volker, et al.
Publicado: (2019)

Cerebellar pilocytic astrocytoma in childhood: Investigating the long-term impact of surgery on cognitive performance and functional outcome
por: Pletschko, Thomas, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rouodvutnklf60h7u6d68lceso